Newsletters

Newsletters

In this edition:

Spotlight of the month: Mathys & Squire teams recommended in The Legal 500 2025 directory for their “unparalleled knowledge and experience in all areas of intellectual property”
Two CRISPR patents pulled from EPO appeals citing procedural concerns
EPO Board of Appeal finds no basis in EPC for requiring description amendments, and opts not to refer questions to the Enlarged Board
Emerging therapeutics and technology provide hope for menopause management
Semiconductor patent applications up 22% globally to 81,000 a year

In this edition:

Spotlight of the month: Why the UK patent system needs an urgent overhaul
Unified Patent Court grants access to evidence but concerns remain over how transparent the new European Court system is going to be
The UK remains a leading innovator – but falls behind on international patent filings

In this edition:

Spotlight of the month: Are written proceedings before the UPC truly public? A tale of three access requests
New Government Minister for AI should make it easier to patent AI technology
Mathys & Squire Managing Associate Harry Rowe was featured in the article by WTR
Mathys & Squire Partner Nicholas Fox was featured in an article by Solicitors Journal
Intellectual Property and Trade Marks (Taylor’s Version)

In this edition:

Spotlight of the month: Emotional Perception High Court ruling overturned by Court of Appeal
UKIPO launches Standards Essential Patents Resource Hub
Ever more patent proprietors opting for the Unitary Patent
Mathys & Squire Partners discuss the importance of protecting IP in the alternative proteins industry
Filings of secret ‘National Security’ patents increase 36% in a year amid military tech developments

In this edition:

Spotlight of the month: Unified Patent Court captures 15% of European patent litigation but still far from being primary European patent court
Changes to the proposed new medicinal products Directive have been approved by the EU Parliament – do they shift the balance between generics and innovators and are they TRIPS compliant?
Mathys & Squire files Petition for Review for Ipsen Bioinnovation
Mathys & Squire recognised as one of Europe’s leading patent firms in the Financial Times 2024 rankings
Fifteen Mathys & Squire attorneys recognised in IAM Patent 1000 2024

In this edition:

Spotlight of the month: Number of drone patents filed worldwide jumps 16% in past year
Does an inventive process entitle you to a claim to an obvious product?
Mathys & Squire promotes three experts to partners
Patenting materials in medical devices at the EPO
Update on Mathys & Squire test case in support of open justice

In this edition:

Spotlight of the month: UPC releases pleadings to the public, but questions remain
Mathys & Squire celebrates World IP Day 2024: IP and the SDGs
Will G1/23 introduce an “on-sale bar” at the EPO?
Mathys & Squire announces the appointment of a new Partner in Munich
Building the future with nature: Boosting biotechnology and biomanufacturing in the EU

In this edition:

Spotlight of the month: Who is using the Unitary Patent System (and who is not)?
Electronics and computing businesses lead Clarivate’s Top 100 Global Innovators 2024 list
Businesses save record amount of corporation tax through Patent Box scheme – £1.4 billion in relief in just a year
Mathys & Squire Partners celebrate women pioneers and inventors
Mathys & Squire sponsors the inaugural Non-Law into Law Conference

In this edition:

Spotlight of the month: MS-RT launches its new range of innovative sport-inspired Ford vehicle designs with the all-new Ford Ranger MS-RT and Transit Custom MS-RT
The supermarket battle continues: Tesco and Lidl clash in UK Court of Appeal
Beyond misconceptions: Exploring the patentability and challenges associated with AI-driven bioinformatics innovations in Europe
Where next for patentability of AI inventions in the UK?
A further blow to transparency at the UPC

Subscribe to our newsletter